Literature DB >> 33036934

Multisystem inflammatory syndrome in SARS-CoV-2 infection mimicking acute appendicitis in children.

Riccardo Guanà1, Camilla Pagliara2, Angelo Giovanni Delmonaco3, Federico Scottoni2, Roberto Bordese4, Giulia Pruccoli5, Fabrizio Gennari2.   

Abstract

Entities:  

Year:  2020        PMID: 33036934      PMCID: PMC7510411          DOI: 10.1016/j.pedneo.2020.09.007

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


× No keyword cloud information.
Dear Editor, A 7 years old boy with no known comorbidities was presented to our attention with complaints of low-grade fever and conjunctivitis for 5 days. In the previous 48 h, he had developed gastroenteritis-like symptoms and hyperpyrexia associated with asthenia and anorexia. The father, a medical doctor, was asymptomatic, while the mother, a biologist, had been experiencing anosmia for one month. He accessed the Emergency Department in April 19, 2020. His abdomen was tense and painful and micro-petechial eruptions were obvious on his limbs. The patient's laboratory findings were: white blood cells count was 11500/mm3; Hemoglobin (Hb) was 11.8 g/dl; platelets (PLTs) were 75000/mm3; C-reactive protein (CRP) was 347 mg/L; procalcitonin (PCT) was 49 ng/ml; D-dimer was 6031; and fibrinogen was 708 mg/dl. Real Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) test for SARS-CoV-2 infection was negative. The patient was admitted for observation and further investigations. During the first night as inpatient, he underwent sudden hypoxia (oxygen saturation <85%) and hypotension, with a systolic blood pressure of 80 mmHg. He was transferred to the Intensive Care Unit where he developed an inflammatory vasculitis associated with a pre-congestive heart failure, leading to a heart profile enlargement at echocardiography, with pericardial effusion (Fig. 1 ).
Figure 1

Echocardiography demonstrating heart profile enlargement with mild pericardial effusion.

Echocardiography demonstrating heart profile enlargement with mild pericardial effusion. Inotropes were started and endocrinological consultation was done. The specialist (endocrinologist) suggested a multisystem inflammatory syndrome in children (MIS-C). Thus, a steroid treatment was administered (2 mg/kg/day intravenous methylprednisolone for 1 week, followed by 1.5 mg/kg/day oral prednisolone for an additional 1 week). Due to the atypical features, he underwent two SARS-Cov-2 tests (RT-PCR) (both negative) and one dosage of seric Immunoglobulin G (IgG) for SARS-Cov-2 (positive). Repeated abdominal ultrasounds revealed a thickening of appendiceal wall without peritoneal free fluid and diffuse thickening of terminal ileum and colon associated with adenomesenteritis (lymphadenopathy and inflammatory fat throughout the mesentery). During the hospitalization, the general conditions progressively improved without airways intubation and mechanical ventilation. The cardiac inotropes were gradually stopped and echocardiography was normal, with minimal residual pericardial effusion (4 mm).

Discussion

SARS-CoV-2 is the causative agent of Coronavirus Disease 2019 (COVID 19). It binds to Angiotensin-Converting Enzyme type-2 (ACE-2) receptor in order to gain entry into the human cells. In infected patients, the clinical presentation depends on tissue distribution of these receptors. ACE-2 is widely expressed on lung alveolar epithelial cells and small intestinal epithelial cells; therefore, the main symptoms are respiratory and gastrointestinal. Gastrointestinal involvement is very common in children, while respiratory distress is most common in adults. Over the past months, several cases of new MIS-C correlating with SARS-CoV-2 infection have been documented among pediatric population. MIS-C definition includes six diagnostic criteria: serious illness leading to hospitalization, age <21 years, fever lasting for at least 24 h, laboratory evidence of inflammation, multisystem organ involvement, evidence of SARS-CoV-2 infection based on RT-PCR, antibody testing, or exposure to persons with Covid-19 in the past month. This emerging entity shows similar features with those of toxic shock syndrome and atypical Kawasaki disease. It occurs about 4–6 weeks after acute SARS-CoV-2 infection, developing from an uninhibited immune response to a prior infection rather than acute manifestation of the viral disease. Among the initial symptoms, high fever and gastrointestinal impairment (that is, abdominal pain, vomiting, and diarrhea) correlate with high values of CRP (>100 mg/L), requiring differential diagnosis of acute appendicitis. When it is neither recognized nor properly treated, it may lead to a left ventricular dysfunction, coronary aneurisms, and heart failure. From our experience, gastrointestinal impairment seems to differ from the traditional presentation of appendicitis. Although abdominal pain is not electively localized in the right iliac fossa, it is more diffuse and often presents symptoms like vomits and diarrhea. Moreover, levels of CRP detected in the blood are extremely high (>200 mg/L), this is uncommon in pediatric patients with acute appendicitis. Abdominal ultrasound shows indirect signs of appendicitis like mesenteric lymphadenopathy or borderline thickening of appendicular wall. Since the hyper-inflammatory syndrome develops after the acute viral event and despite the fact that nasopharyngeal and rectal swab turn out to be negative, at least IgG detected in the blood of these patients are quite high. In conclusion, routine serological test for SARS-CoV-2 should be performed in infants with unusual abdominal pain and elevation of inflammatory markers and who had no diagnosis of appendicitis, since early detection and treatment of SARS-CoV-2 hyper-inflammatory syndrome is vital for prompt management.

Compliance with ethical standards & submission statements

No grant was received for this study. Informed consent was obtained from all individual participants (children's parents) included in the study.

Ethical approval

All procedures performed in this study were in accordance with the ethical standards of the Institutional and National Research Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Declaration of competing interest

None. All Authors declare that they have no conflict of interest.
  5 in total

1.  SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children.

Authors:  Francesco Licciardi; Giulia Pruccoli; Marco Denina; Emilia Parodi; Manuela Taglietto; Sergio Rosati; Davide Montin
Journal:  Pediatrics       Date:  2020-05-21       Impact factor: 7.124

2.  Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic.

Authors:  Zahra Belhadjer; Mathilde Méot; Fanny Bajolle; Diala Khraiche; Antoine Legendre; Samya Abakka; Johanne Auriau; Marion Grimaud; Mehdi Oualha; Maurice Beghetti; Julie Wacker; Caroline Ovaert; Sebastien Hascoet; Maëlle Selegny; Sophie Malekzadeh-Milani; Alice Maltret; Gilles Bosser; Nathan Giroux; Laurent Bonnemains; Jeanne Bordet; Sylvie Di Filippo; Pierre Mauran; Sylvie Falcon-Eicher; Jean-Benoît Thambo; Bruno Lefort; Pamela Moceri; Lucile Houyel; Sylvain Renolleau; Damien Bonnet
Journal:  Circulation       Date:  2020-05-17       Impact factor: 29.690

3.  Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.

Authors:  Leora R Feldstein; Erica B Rose; Steven M Horwitz; Jennifer P Collins; Margaret M Newhams; Mary Beth F Son; Jane W Newburger; Lawrence C Kleinman; Sabrina M Heidemann; Amarilis A Martin; Aalok R Singh; Simon Li; Keiko M Tarquinio; Preeti Jaggi; Matthew E Oster; Sheemon P Zackai; Jennifer Gillen; Adam J Ratner; Rowan F Walsh; Julie C Fitzgerald; Michael A Keenaghan; Hussam Alharash; Sule Doymaz; Katharine N Clouser; John S Giuliano; Anjali Gupta; Robert M Parker; Aline B Maddux; Vinod Havalad; Stacy Ramsingh; Hulya Bukulmez; Tamara T Bradford; Lincoln S Smith; Mark W Tenforde; Christopher L Carroll; Becky J Riggs; Shira J Gertz; Ariel Daube; Amanda Lansell; Alvaro Coronado Munoz; Charlotte V Hobbs; Kimberly L Marohn; Natasha B Halasa; Manish M Patel; Adrienne G Randolph
Journal:  N Engl J Med       Date:  2020-06-29       Impact factor: 91.245

4.  Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020.

Authors:  Silvia Garazzino; Carlotta Montagnani; Daniele Donà; Antonella Meini; Enrico Felici; Gianluca Vergine; Stefania Bernardi; Roberta Giacchero; Andrea Lo Vecchio; Paola Marchisio; Giangiacomo Nicolini; Luca Pierantoni; Ivana Rabbone; Giuseppe Banderali; Marco Denina; Elisabetta Venturini; Andrzej Krzysztofiak; Raffaele Badolato; Sonia Bianchini; Luisa Galli; Alberto Villani; Guido Castelli-Gattinara
Journal:  Euro Surveill       Date:  2020-05

Review 5.  Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).

Authors:  Arno R Bourgonje; Amaal E Abdulle; Wim Timens; Jan-Luuk Hillebrands; Gerjan J Navis; Sanne J Gordijn; Marieke C Bolling; Gerard Dijkstra; Adriaan A Voors; Albert Dme Osterhaus; Peter Hj van der Voort; Douwe J Mulder; Harry van Goor
Journal:  J Pathol       Date:  2020-06-10       Impact factor: 9.883

  5 in total
  3 in total

Review 1.  Pediatric Surgical Care During the COVID-19 Lockdown: What Has Changed and Future Perspectives for Restarting in Italy. The Point of View of the Italian Society of Pediatric Surgery.

Authors:  Francesco Morini; Carmelo Romeo; Fabio Chiarenza; Ciro Esposito; Piergiorgio Gamba; Fabrizio Gennari; Alessandro Inserra; Giovanni Cobellis; Ernesto Leva; Rossella Angotti; Alessandro Raffaele; Sebastiano Cacciaguerra; Mario Messina; Mario Lima; Gloria Pelizzo
Journal:  Front Pediatr       Date:  2022-05-19       Impact factor: 3.569

Review 2.  Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities.

Authors:  Parastoo Hosseini; Mohammad Sadegh Fallahi; Gisou Erabi; Majid Pakdin; Seyed Mahdi Zarezadeh; Arezoo Faridzadeh; Sarina Entezari; Arina Ansari; Mohadeseh Poudineh; Niloofar Deravi
Journal:  Front Mol Biosci       Date:  2022-04-14

3.  Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS) - A mimic of intra-abdominal malignancy.

Authors:  Omar Nasher; Amand Friend; Bhanumathi Lakshminarayanan; Kerry Turner; Mark Wood; Antigoni Deri; Danielle Ingham
Journal:  BMJ Case Rep       Date:  2022-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.